Search results
Results from the WOW.Com Content Network
Pfizer and Moderna vaccines are both safe and have similar effectiveness at preventing COVID-19 illness. Clinical trial data when they were first released in December 2020 showed 95% efficacy for ...
Children who are immunocompromised and chose the Moderna vaccine need an additional dose, which is given about one month after the second shot. The Pfizer vaccine for children 6 months to 4 years ...
These vaccines are better designed to target the existing COVID-19 strains that are circulating than past versions of the shot, with the goal of offering you better protection.
When some people — those age 50 and up and the immunocompromised — became eligible for a second conventional booster shot earlier this year, some decided to go with the other brand. Dr.
The Moderna news followed preliminary results from the Pfizer-BioNTech vaccine candidate, BNT162b2, with Moderna demonstrating similar efficacy, but requiring storage at the temperature of a standard medical refrigerator of 2–8 °C (36–46 °F) for up to thirty days or −20 °C (−4 °F) for up to four months, whereas the Pfizer-BioNTech ...
Pfizer and BioNTech set their price at $120, and Moderna doses will be $129. Novavax shots will be $130 per dose. The vaccine is recommended for everyone six months and older.
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, [2] [33] is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech. For its development, BioNTech collaborated with the American company Pfizer to carry out clinical trials, logistics, and manufacturing.
This photo provided by Pfizer in August 2024 shows a packaging for the company's updated COVID vaccine for ages 12 and up, approved by the U.S. Food and Drug Administration on Thursday, Aug. 22, 2024.